Trial intelligence / Profile preview

Preoperative Chemotherapy vs Chemoradiotherapy in N2 Stage IIIA NSCLC

NCT00452803Phase 2Unknown

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start
Apr 2006
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.

02

Drugs

paclitaxelcisplatin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00452803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00452803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call